Sui Shen

5.1k total citations
159 papers, 4.0k citations indexed

About

Sui Shen is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sui Shen has authored 159 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Radiology, Nuclear Medicine and Imaging, 58 papers in Radiation and 47 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sui Shen's work include Radiopharmaceutical Chemistry and Applications (75 papers), Advanced Radiotherapy Techniques (56 papers) and Medical Imaging Techniques and Applications (38 papers). Sui Shen is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (75 papers), Advanced Radiotherapy Techniques (56 papers) and Medical Imaging Techniques and Applications (38 papers). Sui Shen collaborates with scholars based in United States, China and South Korea. Sui Shen's co-authors include Sally J. DeNardo, Gerald L. DeNardo, Ruby F. Meredith, Jun Duan, Robert T. OʼDonnell, Richard A. Popple, Linda A. Kroger, David L. Kukis, I Brezovich and Diane A. DeNardo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Physical Chemistry B.

In The Last Decade

Sui Shen

154 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sui Shen United States	38	2.5k	1.1k	800	749	649	159	4.0k
Roger M. Macklis United States	34	1.2k 0.5×	1.2k 1.1×	494 0.6×	563 0.8×	786 1.2×	124	3.9k
William D. Bloomer United States	32	836 0.3×	543 0.5×	409 0.5×	226 0.3×	491 0.8×	142	3.2k
Janet Hall France	33	650 0.3×	1.2k 1.1×	783 1.0×	469 0.6×	1000 1.5×	74	4.4k
Christian Menzel Germany	37	1.0k 0.4×	620 0.6×	271 0.3×	467 0.6×	1.8k 2.7×	100	4.6k
Daniel A. Hamstra United States	36	1.7k 0.7×	2.0k 1.9×	806 1.0×	87 0.1×	710 1.1×	159	5.0k
Phuoc T. Tran United States	47	1.0k 0.4×	2.2k 2.1×	460 0.6×	548 0.7×	2.3k 3.5×	254	6.4k
James M. Larner United States	38	851 0.3×	1.8k 1.7×	843 1.1×	191 0.3×	943 1.5×	151	4.3k
Raul C. Urtasun Canada	34	970 0.4×	1.8k 1.6×	450 0.6×	160 0.2×	733 1.1×	89	3.9k
Pierre Verrelle France	30	471 0.2×	1.1k 1.0×	571 0.7×	208 0.3×	946 1.5×	137	3.3k
James M. Slater United States	36	788 0.3×	2.2k 2.0×	1.3k 1.6×	91 0.1×	307 0.5×	130	4.0k

Countries citing papers authored by Sui Shen

Since Specialization

Citations

This map shows the geographic impact of Sui Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui Shen more than expected).

Fields of papers citing papers by Sui Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sui Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui Shen. The network helps show where Sui Shen may publish in the future.

Co-authorship network of co-authors of Sui Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Sui Shen. A scholar is included among the top collaborators of Sui Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui Shen. Sui Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duan, Jingwei, Dennis N. Stanley, Sui Shen, et al.. (2025). Assessing HyperSight iterative CBCT for dose calculation in online adaptive radiotherapy for pelvis and breast patients compared to synthetic CT. Journal of Applied Clinical Medical Physics. 26(5). e70038–e70038. 3 indexed citations

Boggs, Drexell H., Richard A. Popple, Andrew M. McDonald, et al.. (2019). Electromagnetic Transponder Based Tracking and Gating in the Radiotherapeutic Treatment of Thoracic Malignancies. Practical Radiation Oncology. 9(6). 456–464. 8 indexed citations

Meredith, Ruby F., Julien Torgue, Sui Shen, et al.. (2014). Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with ²¹²Pb-TCMC-Trastuzumab. Journal of Nuclear Medicine. 55(10). 1636–1642. 104 indexed citations

Brezovich, I, Xingen Wu, Jun Duan, et al.. (2014). End‐to‐end test of spatial accuracy in Gamma Knife treatments for trigeminal neuralgia a). Medical Physics. 41(11). 111703–111703. 13 indexed citations

Vaklavas, Christos, Ruby F. Meredith, Sui Shen, et al.. (2013). Phase I Study of a Modified Regimen of ⁹⁰ Yttrium–Ibritumomab Tiuxetan for Relapsed or Refractory Follicular or Transformed CD20+ Non-Hodgkin Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 370–379. 3 indexed citations

Shen, Sui, et al.. (2012). SU‐E‐T‐433: Pear‐Shaped Based Dose Optimization for HDR Intracavitary Brachytherapy for Cervical Cancer Patients with Small Uterus. Medical Physics. 39(6Part16). 3804–3804. 1 indexed citations

Fisher, Darrell R., Sui Shen, & Ruby F. Meredith. (2009). MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for ¹¹¹In- and ⁹⁰Y-Ibritumomab Tiuxetan. Journal of Nuclear Medicine. 50(4). 644–652. 58 indexed citations

Popple, Richard A., John A. Antolak, Sung‐Joon Ye, et al.. (2006). Comprehensive evaluation of a commercial macro Monte Carlo electron dose calculation implementation using a standard verification data set. Medical Physics. 33(6Part1). 1540–1551. 57 indexed citations

Shen, Sui, Ruby F. Meredith, Jun Duan, et al.. (2005). Testicular Uptake and Radiation Dose in Patients Receiving Zevalin ^™ and Pretarget ^™ CC49Fusion Protein. Cancer Biotherapy and Radiopharmaceuticals. 20(1). 110–118. 3 indexed citations

10.

Forero‐Torres, Andres, Sui Shen, Hazel B. Breitz, et al.. (2005). Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein. Cancer Biotherapy and Radiopharmaceuticals. 20(4). 379–390. 20 indexed citations

11.

Rogers, Buck E., Peter L. Roberson, Sui Shen, et al.. (2005). Intraperitoneal Radioimmunotherapy with a Humanized Anti-TAG-72 (CC49) Antibody with a Deleted CH2 Region. Cancer Biotherapy and Radiopharmaceuticals. 20(5). 502–513. 19 indexed citations

12.

Forero, Andres, Ruby F. Meredith, M.B. Khazaeli, et al.. (2005). Phase I Study of ⁹⁰ Y-CC49 Monoclonal Antibody Therapy in Patients with Advanced Non-Small Cell Lung Cancer: Effect of Chelating Agents and Paclitaxel Co-Administration. Cancer Biotherapy and Radiopharmaceuticals. 20(5). 467–478. 19 indexed citations

13.

DeNardo, Gerald L., Aina Yuan, D. Goldstein, et al.. (2003). Impact of Interpatient Pharmacokinetic Variability on Design Considerations for Therapy with Radiolabeled MAbs. Cancer Biotherapy and Radiopharmaceuticals. 18(2). 231–237. 6 indexed citations

14.

Forero, Andres, Ruby F. Meredith, M.B. Khazaeli, et al.. (2003). A Novel Monoclonal Antibody Design for Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 18(5). 751–759. 22 indexed citations

15.

Meredith, Ruby F., Sui Shen, Daniel J. Macey, et al.. (2003). Comparison of Biodistribution, Dosimetry, and Outcome from Clinical Trials of Radionuclide-CC49 Antibody Therapy. Cancer Biotherapy and Radiopharmaceuticals. 18(3). 393–404. 13 indexed citations

16.

Shen, Sui, et al.. (2003). Comparison of Methods for Predicting Myelotoxicity for Non-Marrow Targeting I-131-Antibody Therapy. Cancer Biotherapy and Radiopharmaceuticals. 18(2). 209–215. 6 indexed citations

17.

Shen, Sui, Jun Duan, John B. Fiveash, et al.. (2003). Validation of target volume and position in respiratory gated CT planning and treatment. Medical Physics. 30(12). 3196–3205. 48 indexed citations

18.

DeNardo, Gerald L., Sally J. DeNardo, Robert T. OʼDonnell, et al.. (2000). Are Radiometal-Labeled Antibodies Better Than Iodine-131–Labeled Antibodies: Comparative Pharmacokinetics and Dosimetry of Copper-67–, Iodine-131–, and Yttrium-90–Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma. Clinical Lymphoma. 1(2). 118–126. 31 indexed citations

19.

DeNardo, Gerald L., Sally J. DeNardo, Kathleen R. Lamborn, et al.. (1998). Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using ¹³¹ I-LYM-1 Antibody. Cancer Biotherapy and Radiopharmaceuticals. 13(4). 239–254. 78 indexed citations

20.

Shen, Sui, et al.. (1997). Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.. PubMed. 17(3B). 1735–44. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact